Literature DB >> 17641269

Severe speech delay as the presenting symptom of guanidinoacetate methyltransferase deficiency.

J Vodopiutz1, C B Item, M Häusler, H Korall, O A Bodamer.   

Abstract

Guanidinoacetate methyltransferase deficiency typically presents with muscular hypotonia, global developmental delay, extrapyramidal signs, and seizures during infancy and childhood. The authors report a 5-year-old child with guanidinoacetate methyltransferase deficiency who presented with severe speech delay, emphasizing the importance of an early screening for disorders of creatine synthesis and transport in every infant or child with isolated speech delay of unknown cause.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17641269     DOI: 10.1177/0883073807304015

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  3 in total

Review 1.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

2.  Gene therapy for guanidinoacetate methyltransferase deficiency restores cerebral and myocardial creatine while resolving behavioral abnormalities.

Authors:  Suhail Khoja; Jenna Lambert; Matthew Nitzahn; Adam Eliav; YuChen Zhang; Mikayla Tamboline; Colleen T Le; Eram Nasser; Yunfeng Li; Puja Patel; Irina Zhuravka; Lindsay M Lueptow; Ilona Tkachyova; Shili Xu; Itzhak Nissim; Andreas Schulze; Gerald S Lipshutz
Journal:  Mol Ther Methods Clin Dev       Date:  2022-03-28       Impact factor: 5.849

3.  Feasibility of newborn screening for guanidinoacetate methyltransferase (GAMT) deficiency.

Authors:  Marzia Pasquali; Elisabeth Schwarz; Maren Jensen; Tatiana Yuzyuk; Irene DeBiase; Harper Randall; Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2013-11-26       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.